Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Aevi Genomic Medicine, Inc. (NASDAQ: GNMX).

Full DD Report for GNMX

You must become a subscriber to view this report.


Recent News from (NASDAQ: GNMX)

Aevi Genomic down 6% on Q1 result
Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com...
Source: SeekingAlpha
Date: May, 15 2018 09:01
Aevi Genomic reports Q1 results
Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 15 2018 08:41
Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update
PHILADELPHIA , May 15, 2018 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018 and provided an overview of the Company's recent corporate progress. First Qu...
Source: PR Newswire
Date: May, 15 2018 08:30
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX
Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi...
Source: Business Wire
Date: April, 30 2018 09:35
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX...
Source: PR Newswire
Date: April, 29 2018 18:56
Investor Expectations to Drive Momentum within Brooks Automation, Broadridge Financial Solutions, Vivint Solar, Northwest Natural Gas, Aevi Genomic Medicine, and Northern Oil and Gas - Discovering Underlying Factors of Influence
NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Brooks Automation, Inc. (NASDAQ:BRKS), Broadridge Financial Solutions, I...
Source: GlobeNewswire
Date: April, 06 2018 08:15
Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow
The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 29 2018 13:02
Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference
PHILADELPHIA , March 20, 2018 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March ...
Source: PR Newswire
Date: March, 20 2018 08:00
Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: March, 14 2018 13:46
Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript
Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper – Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe...
Source: SeekingAlpha
Date: March, 13 2018 13:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-171.521.621.631.5273,638

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-256,65918,30836.3721Short
2018-05-2413,73624,54655.9602Short
2018-05-2317,14359,04529.0338Cover
2018-05-2224,22275,70831.9940Cover
2018-05-212,23150,3344.4324Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GNMX.


About Aevi Genomic Medicine, Inc. (NASDAQ: GNMX)

Logo for Aevi Genomic Medicine, Inc. (NASDAQ: GNMX)

Not available

 

Contact Information

 

 

Current Management

  • John Leaman / CFO
  • Barbara G. Duncan /

Current Share Structure

  • Market Cap: $88,412,525 - 05/11/2018
  • Issue and Outstanding: 59,337,265 - 03/09/2018

 


Recent Filings from (NASDAQ: GNMX)

Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: May, 16 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: May, 16 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: May, 16 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 15 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: May, 15 2018
Information for Proxy Statement under Rule 14a-101
Filing Type: DEFR14AFiling Source: edgar
Filing Date: May, 01 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018

 

 


Daily Technical Chart for (NASDAQ: GNMX)

Daily Technical Chart for (NASDAQ: GNMX)


Stay tuned for daily updates and more on (NASDAQ: GNMX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: GNMX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GNMX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of GNMX and does not buy, sell, or trade any shares of GNMX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/